Genzyme Picks InnoCielo Meridian Enterprise, FDA Module
RIJSWIJK,
The Netherlands, Nov 5, 2008 - BlueCielo ECM Solutions, a leading global
software company offering Engineering Content Management (ECM) solutions,
announced today that Genzyme Corporation, one of the world’s foremost
biotechnology companies, has chosen BlueCielo to implement and validate its
innovative ECM solution, InnoCielo Meridian Enterprise and the FDA Module,
at four of the company’s worldwide locations. These locations include
Framingham, MA, USA; Suffolk, United Kingdom; Waterford, Ireland and Geel,
Belgium. Genzyme continues to demonstrate its leadership by implementing
sophisticated technology that will take it to new levels of efficiency and
compliance. The FDA Module provides the technical controls related to
compliance with 21 CFR Part 11 for their engineering drawings.
With many established products and services helping patients in nearly 90
countries, Genzyme is a leader in the effort to develop and apply the most
advanced technologies in the life sciences. Founded in Boston in 1981,
Genzyme has grown from a small start-up to a diversified enterprise with
2007 revenues of $3.8 billion and 10,000 employees in locations spanning the
globe.
“We continue to see a rapid adoption of the InnoCielo product suite in
the biotechnology and pharmaceutical sectors,” says Martijn Janmaat,
BlueCielo’s CEO. “Genzyme is a great example of the growing number of global
life sciences companies that are bringing products to market faster by
optimizing their processes in managing their critical engineering content.
With efficient validation processes and the availability of accurate
engineering information to the relevant people throughout the enterprise,
companies are now much better able to manage and share all required good
manufacturing practices (GMP) documentation and comply with the FDA’s 21 CFR
Part 11 regulation much more easily.”
About BlueCielo ECM Solutions
BlueCielo ECM Solutions provides Engineering Content Management and
Application Integration solutions for owner/operators in multiple vertical
industries including energy, oil & gas, petrochemical, government,
pharmaceutical, and discrete and process manufacturing. BlueCielo has more
than two decades of industry experience with over 275,000 users in 50+
countries worldwide. The company has offices in the USA, UK, Russia, Germany
and the Netherlands, together with an extensive global network of
established partners.
BlueCielo ensures a high level of service and support on a truly
worldwide scale for its leading software solutions InnoCielo Meridian
Enterprise, InnoCielo ImandrA for IBM FileNet P8 and InnoCielo TeamWork.
For more information, visit
www.bluecieloecm.com.
--------
If news like this is important to you, sign up for our TenLinks Daily at http://www.tenlinks.com/NEWS/sub_unsub.htm.
Related News
Feb 01 - BlueCielo Appoints van der Scheer as New CEO Aug 26 - BlueCielo Releases InnoCielo Publisher 2009 Aug 3 - BlueCielo FY08 Revenue Up 37% to $18.3M with $3.4M Profit Jul 22 - BlueCielo Releases InnoCielo Meridian, TeamWork 2009 Jun 19 - InnoCielo 2009 to Support Oracle AutoVue 2D Pro for Viewing Mar 16 - BlueCielo Acquires 51% Shares of Brazilian Organization Feb 3 - BlueCielo Renovates Mexican Non-Profit Clinic, Donates $10K Jan 14 - BlueCielo Releases InnoCielo Workflow Module 2008a Jan 13 - BlueCielo Ships InnoCielo Meridian, TeamWork 2008a Dec 18 - BlueCielo to Acquire Brazil's SKA, GAMA Reseller Activities Dec 11 - BlueCielo Acquires 49% Asset of Brazil's PONTODOC Dec 1 - BlueCielo Promotes Sallade to COO, Moves Office to Exton Nov 5 - Genzyme Picks InnoCielo Meridian Enterprise, FDA Module Aug 12 - BlueCielo Releases InnoCielo Global Collaboration Framework Aug 12 - BlueCielo Releases InnoCielo Global Collaboration Framework Jul 24 - BlueCielo Releases InnoCielo Asset Management Module 2008 Jul 22 - BlueCielo Releases InnoCielo Publisher 2008
Source: Material used in press releases is often supplied by external
sources and used as is.
|